National Stem Cell Holding, Inc. Has Engaged BMA Securities to Assist and Advise the Company With Its Current Capital Raise of ...( MOUNTAINSIDE N.J. Feb. 19 /- Nati...)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
National Stem Cell Holding, Inc. Has Engaged BMA Securities to Assist and Advise the Company With Its Current Capital Raise of $3,500,000
Date:2/19/2008
MOUNTAINSIDE, N.J., Feb. 19 /PRNewswire-FirstCall/ -- National Stem Cell Holding, Inc. (OTC: NHGI) today announced the engagement of Burt Martin Arnold Securities, Inc. ("BMA Securities") to provide advisory and investment banking services with respect to assisting and advising the company with a current capital raise of $3,500,000.
BMA Securities is a FINRA member full service brokerage firm. BMA Securities offers a wide array of financial services, which include: market making, institutional trading, investment banking, advisory and consulting services.
National Stem Cell President Michael Cohen, stated: "We welcome BMA Securities to our team and look forward to a long working relationship with them. They are assisting us with our current funding and possibly future mergers and acquisitions the company is looking at in the future."
For more information on National Stem Cell Holding, Inc. please contact us at the company website: http://www.nationalstemcell.com or http://www.pinksheets.com .
About National Stem Cell Holding, Inc.
National Stem Cell Holding, Inc. is a hybrid biotechnology company
focused on developing therapeutics based upon the use of human stem cells
and their derivatives. The term 'hybrid' refers to both the business model
as well its product line. The Company is developing a pipeline of
proprietary stem cell therapeutics with particular focus on diabetes. Many
of the currently incurable diseases associated with aging are caused by the
degeneration of specific cell types in the body. These include but are not
limited to: cancer, heart disease, diabetes, neurodegenerative diseases and
auto immune conditions. In addition to its work with stem cell
therapeutics, the Company is leveraging its commercial infrastructure and
product development capabilities of its wholly-owned subsidiaries The Sperm
'/>"/>
| SOURCE National Stem Cell Holding, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. National Fire Protection Association (NFPA) Sets New National Standard for CO Screening by Pulse CO-Oximetry(TM)
2. National Nanotechnology Initiative releases its fiscal year 2009 budget and highlights
3. Addressing the Pharmacist Shortage: Medco Labor Coalition(TM) Launches National Scholarship Program to Support the Development of the Next Generation of Pharmacists
4. Siemens and National Jewish Medical and Research Center Form Strategic Alliance to Advance Shared Vision of Personalized Medicine
5. National Public Radio (NPR) Features Broadcast Articles on NanoLogix Hydrogen Bioreactor Operation at Welchs Foods
6. PAREXEL International Announces 2-For-1 Stock Split
7. Cryo-Cell International, Inc. Reports Results for Fiscal 2007
8. Schering-Plough and OraSure Technologies Sign International Collaboration for Rapid Point-of-Care Oral Hepatitis C Test
9. U.S. Preventive Medicine National Policy Advisor Gov. Tommy Thompson to Propose Prevention is the Solution at UBS Global Health Services Conference
10. Experts and Representatives From Leading International Health-Care Organizations Call to Stop the Hypertension Pandemic, a Worldwide Silent Killer
11. Velcura Therapeutics, Inc. Teams with International Discovery Sourcing Consultants to Develop New Therapeutic Molecules for Cancer and Bone Disease
Post Your Comments:
(Date:11/20/2009)...ntly announced that Dr. Dominique Hebrault will pr...nalytical Technology (PAT) in Green Chemistry and ... (PRWEB) November 20, 2009 -...ology (PAT) in Green Chemistry and Green Engineeri...nology (PAT) case studies will be presented on how...
(Date:11/19/2009)...Call/ -- Omeros Corporation (Nasdaq: OMER ) today...rd quarter ended September 30, 2009. For the three...a net loss of $3.9 million, or $1.34 per share, as...per share, for the same period in 2008. For the ni...ported a net loss of $15.5 million, or $5.29 per s...
(Date:11/19/2009)...tCall/ -- NeoStem, Inc. (NYSE Amex: NBS ), announ... its shareholders, discussing the Company,s acquis...icals Holdings, Inc. (CHBP), an integrated bio-pha... of China. The merger gives NeoStem a controlling ...., CHBP,s primary operating subsidiary and a promi...
(Date:11/19/2009)...19 MONITORING FORCE GmbH,announced...nserin in the,indication treatment-relevant levodo...rphan drug status designation with the European Me... is a complication of the mainstay,treatment in ad... those,affected, since it may be disabling for the...
Breaking Biology Technology:Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2[0] Process Analytical Technology (PAT) in Green Chemistry and Green Engineering[0] Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights[0] NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company[0] MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug"
... TSX Exchange Symbol: RVX, CALGARY, Apri...Resverlogix" or the "Company") (TSX:RVX) announced...a safety, tolerability and pharmacokinetics,study ...ses the,dyslipidemia market. "Initial results from... J. McCaffrey, President & CEO of Resverlogix. "As...
...SM), a developer of follow-on biologics (FOBs) and...Allan, Ph.D., CEO of Insmed, will present at,the C...n FOBs, on April 29,2008 at 2:15 PM Eastern Time i..."Evaluate the Legislative, Economic and,Scientific...rs and,Follow-On Biologics," will be held at the D...
...oterrorism, Says UK Board Mem...fense Corp., the only company in,the world to deve...destroy,a biohazardous substance while maintaining...ounced it has partnered with General Lord Guthrie,...blish new security,markets for the BioDefense Mail...
Other Biology Technology:Dosing for RVX-208 Phase 1a Clinical Study Completed 2Insmed to Present at CBI Follow-On Biologics Conference 2Insmed to Present at CBI Follow-On Biologics Conference 3Boston-Based BioDefense Corp. Announces New UK Partnership to Expand Markets for Biohazard Protection 2Boston-Based BioDefense Corp. Announces New UK Partnership to Expand Markets for Biohazard Protection 3(Date:11/22/2009)...h Centre, a partnership of the University of Briti...tal Health Research Institute, have uncovered new ...ls die following a stroke, as well as a possible w...dy were recently published online in Nature Medic...tinue to die even after blood flow has been restor...
(Date:11/20/2009)...ad studies about the health benefits of having a l...ar level, where amino acids known as cysteines are...hen paired up with other cysteines. , Now, resea...olleagues in Belgium, have discovered a new antiox...esearch appears in the Nov. 20 issue of the journa...
(Date:11/20/2009)...9) Scientists from the Marine Biogeochemistry and...arch Laboratory (NRL) organized and led a team of ...expedition to initiate methane hydrate exploration...iation of sediment contribution to Arctic climate ...Polar Sea as a research platform, three cross-shel...
Breaking Biology News(10 mins):New understanding about mechanism for cell death after stroke leads to possible therapy 2Saving the single cysteine: New antioxidant system found 2International expedition investigates climate change, alternative fuels in Arctic 2100+ Nurses to Rally in SF Wed to Demand Stronger Swine Flu Safety Protections 3A California Hospitals Remain Unprepared Despite First Nurse Death 53680 1100+ Nurses to Rally in SF Wed to Demand Stronger Swine Flu Safety Protections 3A California Hospitals Remain Unprepared Despite First Nurse Death 53680 2100+ Nurses to Rally in SF Wed to Demand Stronger Swine Flu Safety Protections 3A California Hospitals Remain Unprepared Despite First Nurse Death 53680 3ViroPharma Announces Support by Advisory Committee of The Office of Generic Drugs Proposed Guidelines for Developing Generic Versions of Oral Vancomyc 53677 1ViroPharma Announces Support by Advisory Committee of The Office of Generic Drugs Proposed Guidelines for Developing Generic Versions of Oral Vancomyc 53677 2ViroPharma Announces Support by Advisory Committee of The Office of Generic Drugs Proposed Guidelines for Developing Generic Versions of Oral Vancomyc 53677 3ViroPharma Announces Support by Advisory Committee of The Office of Generic Drugs Proposed Guidelines for Developing Generic Versions of Oral Vancomyc 53677 4Premier of Split Estate at DocuWeeks 2009 to Call National Attention to Urban Drilling in New York and Los Angeles 53675 1Premier of Split Estate at DocuWeeks 2009 to Call National Attention to Urban Drilling in New York and Los Angeles 53675 2Premier of Split Estate at DocuWeeks 2009 to Call National Attention to Urban Drilling in New York and Los Angeles 53675 3...dentified the proteins that allow specific brain c...aks what can come into the cell. The findings, des...researchers harness the process, perhaps one day u...disease. , Much as turning the television dial cha...cells are able to change what they allow in by swa...
...eaded by Professor Hans-Georg Kräusslich at Heidel...Hanswalter Zentgraf, Division of Applied Tumor Vir...man Cancer Research Center, DKFZ), have been the f... for visual investigations without inhibiting the ...beling permits scientists to observe the behavior ...
... secreted by mussels and a polymer that repels cel...rsity have designed a versatile new two-sided coat... , Currently the longevity of certain medical imp... in the body gradually accumulate on the devices (...and threatening patients with infections. Unfortun...
Other Biology News:Some Brain Cells Change Channels 2Some Brain Cells Change Channels 3New Species of Coral Discovered Off Southern California 2Innovative coating could give medical implants a longer life 2Chaperone Sampler Kit from BD Biosciences Pharmingen
SH3 Proteins II Sampler Kit from BD Biosciences Pharmingen
Mouse Anti-SOCS3 Monoclonal Antibody, Unconjugated, Clone SOC-25 from BioLegend
Caveolin Sampler Kit from BD Biosciences Pharmingen
Biology Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |